pyroglutamic acid/sykursýki

Krækjan er vistuð á klemmuspjaldið

Veldu tegund tegund

7 niðurstöður

Maternal Early Pregnancy Serum Metabolites and Risk of Gestational Diabetes Mellitus.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

BACKGROUND Significant gaps remain in the understanding of genetic and environmental risk factors, as well as related mechanisms that contribute to gestational diabetes mellitus (GDM). OBJECTIVE This study aimed to investigate early pregnancy maternal serum metabolites and subsequent risk of

Anti-diabetic effect of pyroglutamic acid in type 2 diabetic Goto-Kakizaki rats and KK-Ay mice.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

With the rapidly increasing prevalence of type 2 diabetes mellitus (T2DM), specific dietary components with anti-diabetic efficacy could be one strategy with therapeutic potential. In the present study, the anti-diabetic effects of an amino acid, pyroglutamic acid (PA), found in vegetables and

Fasting serum α‑hydroxybutyrate and pyroglutamic acid as important metabolites for detecting isolated post-challenge diabetes based on organic acid profiles.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

The aim of this study was to develop a method to detect serum organic acid profiles in patients with isolated post-challenge diabetes (IPD) and to compare the metabolites between IPD patients, type 2 diabetes mellitus (T2DM) and healthy controls. We developed a gas chromatography-mass spectrometry

Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

OBJECTIVE Metabolic profiling of small molecules offers a snapshot of physiological processes. To identify metabolic signatures associated with type 2 diabetes and impaired fasting glucose (IFG) beyond differences in glucose, we used mass spectrometry-based metabolic profiling. METHODS Individuals

A metabolic profiling strategy for biomarker screening by GC-MS combined with multivariate resolution method and Monte Carlo

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

A GC-MS based metabolic profiling method via a multivariate resolution method and Monte Carlo PLS-DA is proposed for screening potential biomarkers, and applied to Type 2 diabetes mellitus. The metabolic profiles of plasma samples from healthy control and Type 2 diabetes mellitus patient groups were

Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Background: Although an increased arterial stiffness has been associated with traditional coronary risk factors, the risk factors and pathology of arterial stiffness remain unclear. In this study, we aimed to identify the plasma

5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.

Aðeins skráðir notendur geta þýtt greinar

Skráðu þig / skráðu þig

Diabetic nephropathy (DN) is a leading cause of end-stage renal disease. Microalbuminuria (MA) is widely used to predict early progressive renal function decline (ERFD) of DN in type 2 diabetes mellitus (T2D) patients, but the sensitivity and specificity of MA have been questioned.

Skráðu þig á
facebook síðu okkar

Herbal & Natural Medicine

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

Virkar á 55 tungumálum
Jurtalækningar studdir af vísindum
Jurtaviðurkenning eftir ímynd
Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
Lestu vísindarit sem tengjast leit þinni
Leitaðu að lækningajurtum eftir áhrifum þeirra
Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum